Medicines Transparency Kyrgyzstan


Published on

Presentation on medicines transparency in Kyrgyzstan at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

Published in: Health & Medicine, Technology
1 Comment
  • After you got all the information on Fioricet, another point on your agenda should be the price for it. resolves this problem. Now you can make the decision to buy.
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Title of presentation 04/06/09 MeTA
  • Medicines Transparency Kyrgyzstan

    1. 1. MeTA in Kyrgyzstan MeTA in Kyrgyzstan Mariam Djankorozova, MeTA Co-Director 16/05/2008
    2. 2. Agenda <ul><li>Medicines Issues and Priorities in Kyrgyzstan </li></ul><ul><li>Past and Current Experience in Addressing Medicines Issues </li></ul><ul><li>Future Plans to Address Medicines Issues through MeTA </li></ul><ul><li>Intended outcomes </li></ul>16/05/2008
    3. 3. Overview: Medicines Issues and Priorities <ul><li>Limited access to medicines </li></ul><ul><ul><li>Limited affordability and availability </li></ul></ul><ul><ul><ul><li>Especially important for chronic diseases highly prevalent in KG </li></ul></ul></ul><ul><ul><ul><li>Major problem in rural areas (70% population lives in rural areas) </li></ul></ul></ul><ul><ul><ul><ul><li>1 pharmacy:1500 people urban; 1 pharmacy:4500 people rural </li></ul></ul></ul></ul><ul><li>Low Quality of Medicines </li></ul><ul><ul><li>Counterfeit medicines from abroad; unable to fight against smuggled medicines </li></ul></ul><ul><li>Limited access to reliable & timely information on medicines </li></ul><ul><ul><li>Drug info. system under-developed, no info. on price, quality </li></ul></ul>06/04/09
    4. 4. Limited access to medicines <ul><li>Case of Hypertension </li></ul><ul><ul><li>Several important and less expensive medicines (HCTZ) are not prescribed by doctors or recommended by pharmacists in favour of medicines that are highly promoted (enalapril) </li></ul></ul><ul><ul><ul><li>Written prescription differs from oral directions given by doctor </li></ul></ul></ul><ul><ul><ul><li>People cannot afford expensive medicines; Insurance system insufficiently funded to adequately cover all beneficiaries </li></ul></ul></ul><ul><ul><ul><li>Preference for branded generics that are much more expensive </li></ul></ul></ul><ul><ul><ul><li>No mechanism to control promotion </li></ul></ul></ul><ul><ul><li>MeTA offers a mechanism to provide information to counteract promotion; engage CSOs to reach public with information </li></ul></ul>06/04/09
    5. 5. Low Quality of Medicines <ul><li>Medicines entering country through official channels </li></ul><ul><ul><li>80 medicines per year are withdrawn due to poor quality </li></ul></ul><ul><ul><li>Currently no link between DRA and customs </li></ul></ul><ul><li>Medicines entering country through informal channels </li></ul><ul><ul><li>Major problem; mountainous country difficult to monitor; </li></ul></ul><ul><ul><li>Impossible to differentiate counterfeit from legitimate medicines </li></ul></ul><ul><ul><li>Sold to pharmacies at low prices; </li></ul></ul><ul><ul><li>Some are substandard (lower amount of active ingredient, some have no active ingredient) </li></ul></ul><ul><li>MeTA offers opportunity to collect information and link activities between customs and DRA; disseminate information on quality of medicines in official and informal channels to consumers; CSOs can assist DRA to monitor and educate </li></ul>06/04/09
    6. 6. Limited access to reliable & timely information on medicines <ul><li>Need information on: </li></ul><ul><ul><li>Import, legislation, licensing, certification, registration, quality, price, procurement </li></ul></ul><ul><li>MeTA can provide a mechanism for creating a single space on internet where all information can be accessible to all population (consumers and professionals); mobile phones may be an alternative to internet in rural areas; price monitoring will be key </li></ul><ul><ul><li>Must be two-way communication with feedback from population, utilizing CSOs for outreach </li></ul></ul>06/04/09
    7. 7. Summary <ul><li>Kyrgyzstan has been a leader in the region in addressing pharmaceutical issues </li></ul><ul><ul><li>One of the first countries to implement national drug policy, essential medicines list, standardized national treatment guidelines with training </li></ul></ul><ul><ul><li>Insurance system for medicines, projects to create networks of pharmacies in rural areas </li></ul></ul><ul><li>Still, more work is needed; Ultimate goal is to improve access to medicines, especially for the poor </li></ul><ul><li>MeTA offers opportunity for government, private sector and civil society to work together and disclose information on medicines towards goals of increasing access to medicines </li></ul>06/04/09
    8. 8. Where to Get More Information <ul><li>Department of Drug Provision and Medical Equipment </li></ul><ul><ul><li> </li></ul></ul><ul><li>Health Insurance Fund </li></ul><ul><ul><li> </li></ul></ul><ul><li>Kyrgyz Republic National Health Care Reform Program </li></ul><ul><ul><li> </li></ul></ul>06/04/09
    9. 9. Thank you! <ul><li>Name of presenter: Mariam Djankorozova </li></ul><ul><li>Email: </li></ul><ul><li>Mobile number: + 996 555 929412 </li></ul><ul><li>International Secretariat, </li></ul><ul><li>MeTA: </li></ul><ul><li>DFID: </li></ul>06/04/09
    10. 10. Kyrgyzstan